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Abstract
Signalling of the epithelial splicing variant of the fibroblast growth factor receptor 2 (FGFR2b) induces both autophagy and phagocytosis in human
keratinocytes. Here, we investigated, in the cell model of HaCaT keratinocytes, whether the two processes might be related and the possible
involvement of PLCc signalling. Using fluorescence and electron microscopy, we demonstrated that the FGFR2b-induced phagocytosis and autop-
hagy involve converging autophagosomal and phagosomal compartments. Moreover, the forced expression of FGFR2b signalling mutants and the
use of specific inhibitors of FGFR2b substrates showed that the receptor-triggered autophagy requires PLCc signalling, which in turn activates
JNK1 via PKCd. Finally, we found that in primary human keratinocytes derived from light or dark pigmented skin and expressing different levels of
FGFR2b, the rate of phagocytosis and autophagy and the convergence of the two intracellular pathways are dependent on the level of receptor
expression, suggesting that FGFR2b signalling would control in vivo the number of melanosomes in keratinocytes, determining skin pigmentation.
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Introduction
The fibroblast growth factor receptors (FGFRs) are receptor tyrosine
kinases (RTKs) regulating several cellular processes such as prolifer-
ation, differentiation, migration and survival [1, 2]. FGF binding to
FGFRs induces the receptor dimerization and transphosphorylation,
which activates different intracellular signalling pathways. The main
downstream substrates of FGFRs are the phospholipase Cc (PLCc),
which associates with FGFRs in a ligand-inducible manner via specific
receptor tyrosine residues, and the FGFR substrate 2 (FRS2). FRS2
phosphorylation leads to subsequent activation of both RAS/mitogen-
activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/
AKT signalling pathways [3]. Other pathways may be also activated
downstream FGFRs, including the Jun N-terminal kinases (JNKs) path-
way [4], which can be activated downstream RAS by the MAPKKs,
MKK4 and MKK7 [5], or via protein kinase C delta (PKCd) [6, 7].
FGFRs are expressed on different tissues, where the specific alter-
native splicing of the IgIII domain in FGFR1–3 produces IIIb epithelial
and IIIc mesenchymal isoforms determining the ligand specificity
[1, 2]. The FGFR2b/KGFR is exclusively expressed in epithelial cells
[8] and can be activated by the stimulation with its specific ligand
FGF7/KGF [9]. We have recently demonstrated that FGFR2b expres-
sion and its signalling trigger autophagy in human keratinocytes, and
the use of specific inhibitors indicated that this effect is PI3K/AKT/
mTOR-independent [10]. Moreover, the selective block of autophago-
some fusion with lysosomes demonstrated that FGFR2b-mediated
signalling stimulates the autophagosome assembly, but also their
turnover upon a prolonged autophagic stimulus [10]. In addition,
recent findings from our group showed that the expression of the E5
oncoprotein of human papillomavirus type 16 (HPV16 E5) is able to
inhibit the FGF7-induced autophagy through down-regulation of
FGFR2b [11].
A functional and molecular link between autophagy and phagocy-
tosis appears to exist, at least in macrophages. In fact, it has been
demonstrated that autophagy induction promotes the engulfment of
phagosomes containing bacteria in autophagosomes to allow
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pathogen elimination [12, 13]. However, other studies have shown
that the induction of autophagy leads to down-modulation of the
phagocytosis of yeast particles in murine macrophages [14] and that
the phagocytosis is enhanced in macrophages from ATG7-deficient
mice [15]. In addition, TLR signalling during phagocytosis induces a
rapid recruitment of BECN1 and microtubule-associated protein 1
light chain 3 (LC3) to the phagosomes, apparently without the forma-
tion of conventional autophagosomes, in the process called LC3-
associated phagocytosis (LAP) [16]. Several other ATG proteins are
also required for different steps of LAP, including the phagosome
maturation [16, 17].
As we have previously demonstrated that FGF7-dependent activa-
tion of FGFR2b and its downstream PLCc signalling trigger phagocy-
tosis and melanosome uptake in human keratinocytes [18], here we
investigated the possible interplay between FGFR2b-induced autop-
hagy and phagocytosis and the involvement of PLCc signalling also in
the receptor-mediated autophagic process.
Materials and methods
Cells and treatments
The human keratinocyte cell line HaCaT [19] was cultured in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with 10% foetal
bovine serum (FBS) plus antibiotics. Primary cultures of human ker-
atinocytes derived from light healthy skin (light HKs) were obtained
from patients attending the Dermatology Unit of the Sant’Andrea Hospi-
tal of Rome; all patients were extensively informed and their consent
for the investigation was given and collected in written form in accor-
dance with guidelines approved by the management of the Sant’Andrea
Hospital. Primary keratinocytes were isolated and cultured as previously
described [20]. Primary cultures of darkly pigmented HKs (dark HKs)
were purchased from Cascade Biologics (Portland, OR, USA).
Cells were transiently transfected with pCI-neo empty vector (HaCaT
pCI-neo), with pCI-neo expression vector containing human FGFR2b
(HaCaT FGFR2b WT) or a kinase-negative mutant FGFR2b Y656F/Y657F
(HaCaT FGFR2b kin) [21] or a signalling mutant FGFR2b Y769F
(HaCaT FGFR2b Y769F) [22]. Alternatively, cells were transiently trans-
fected with pEGFP-C2 expression vector containing LC3 (engineered by
Dr. Fimia, National Institute for Infectious Diseases IRCCS ‘L. Spallan-
zani’, Rome, Italy; and kindly provided by Prof. Francesco Cecconi, Tor
Vergata University of Rome, Italy). jetPEITM DNA Transfection Reagent
(Polyplus-transfection, New York, NY, USA, 10-40) was used for trans-
fection of HaCaT cells, while FuGENE HD Transfection reagent (Pro-
mega, Madison, WI, USA, E2311) was used for transfection of HKs.
For RNA interference and ULK1 or Rubicon silencing, HaCaT cells
were transfected with ULK1 small interfering RNA (ULK1 siRNA) (Santa
Cruz Biotechnology, Santa Cruz, CA, USA, sc-44182), or with Rubicon
small interfering RNA (Rubicon siRNA) (Santa Cruz Biotechnology, sc-
78326) or with an unrelated siRNA as a control (control siRNA) (Santa
Cruz Biotechnology, sc-37007), using Lipofectamine 2000 Transfection
Reagent (Invitrogen, Carlsbad, CA, USA, 11668-019) according to the
manufacturer’s protocol.
For stimulation of growth factors, cells were serum-starved and incu-
bated with FGF7 (Upstate Biotechnology, Lake Placid, NY, USA, 01-118)
100 ng/ml for 24 hrs at 37°C.
For inhibition of FGFR2b activity, cells were preincubated with a speci-
fic FGFR tyrosine kinase inhibitor, SU5402 (25 lM; Calbiochem, Notting-
ham, UK, 572630), for 1 hr before treatment with the growth factor.
To inhibit AKT or ERK or JNK or PKCd, cells were respectively incu-
bated with the specific AKT inhibitor 1L-6-hydroxymethyl-chiro-inositol
2-(R)-2-O-methyl-3-O-octadecylcarbonate (1 lM; Calbiochem, 124005)
or with the specific MEK1/2 inhibitor PD0325901 (1 lM; Sigma-Aldrich,
St. Louis, MO, USA, PZ0162) or with the specific JNK inhibitor
SP600125 (50 lM; Sigma-Aldrich, S5567) or with the specific PKCd
inhibitor rottlerin (0.5 lM; Calbiochem, 557370) for 1 hr at 37°C before
treatment with FGF7 in the presence of each inhibitor.
To irreversibly block the fusion between autophagosomes and lyso-
somes, HaCaT cells were incubated with bafilomycin A1 (20 nM;
Sigma-Aldrich, B 1793) [23] for 3 hrs at 37°C after treatment with
FGF7 in the presence of the inhibitor.
To analyse the uptake of beads in keratinocytes, cells were incubated
with red fluorescent microspheres 0.5 and 1 lm in diameter (Fluo-
Spheres; Molecular Probes, Eugene, OR, USA, F8812 and F8821) at the
concentration of 72 9 107 particles/ml and 36 9 107 particles/ml for
Fig. 1 Presence of internalized beads in autophagosomes after FGF7 stimulation. (A) HaCaT cells were transiently transfected with pEGFP-C2-LC3
construct (left panels) or cotransfected with LC3 construct and ULK1 siRNA, Rubicon siRNA or an unrelated siRNA as control (right panels). Cells
were then serum-starved and stimulated with FGF7 for 24 hrs and with inert latex red fluorescent beads for the last 4 hrs. Cell nuclei were stained
with DAPI. Quantitative fluorescence analysis shows that while in cells singly transfected with EGFP-LC3 the serum deprivation only induces an
increase in the number of EGFP-LC3-positive dots per cell, FGF7 stimulation enhances either the number of EGFP-LC3-positive dots or fluorescent
bead uptake per cell (left panels); a partial colocalization between LC3 and fluorescent beads is detectable only in response to FGF7 (left panels).
ULK1 depletion reduces, while Rubicon depletion further increases the number of EGFP-LC3-positive dots compared to control cells (right panels);
the colocalization between EGFP-LC3 and the fluorescent beads in response to FGF7 is significantly reduced only by ULK1 depletion (right panels).
None of the siRNAs used significantly affects beads uptake (right panels). The quantitative analysis was performed as described in Materials and
Methods, and results are expressed as mean values  S.E. Student’s t-test was performed, and significance levels were defined as P < 0.05:
*P < 0.001 versus the corresponding FGF7-unstimulated cells, **P < 0.001 versus the corresponding serum-cultured cells, ***P < 0.01 versus the
corresponding FGF7-unstimulated cells, ^P < 0.001 versus HaCaT control siRNA cells, ^^P < 0.05 versus HaCaT control siRNA cells, NS (not signifi-
cant) versus the corresponding serum-cultured cells and versus HaCaT control siRNA cells. Bar: 10 lm. (B) Ultrastructural analysis of HaCaT cells
stimulated with FGF7 in the presence of beads as described above. Single (i, ii, iii, asterisks) and clustered beads (iv, asterisks) were visible in either
single-membrane (ii, arrows) or double-membrane vacuoles (ii, iii, iv, arrowheads) corresponding to phagosomes and autophagosomes, respectively.
The clustered beads enclosed in a double-membrane vacuole also appeared singly surrounded by a single membrane (iv, red arrows). AV: auophagic
vacuole; ER: endoplasmic reticulum; Ly: lysosome; M: mitochondrion; Nu: nucleus; PH: phagosome; PM: plasma membrane. Bar: 0.25 lm.
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4 hrs, respectively. These microspheres are inert latex fluorescent
spherical particles loaded with a red (580/605) fluorescent dye which
show little or no photobleaching.
To evaluate the effects of FGFR2b activation on the phagocytic abil-
ity, the uptake was performed in the presence of 100 ng/ml FGF7.
Immunofluorescence
Cells, grown on coverslips and incubated with or without FGF7 as above,
were fixed with 4% paraformaldehyde (Electron Microscopy Sciences,
Hatfield, PA, USA, 157-8) in PBS for 30 min. at 25°C followed by treat-
ment with 0.1 M glycine (Sigma-Aldrich, 50046) for 20 min. at 25°C and
with 0.1% Triton X-100 for an additional 5 min. at 25°C to allow perme-
abilization. Cells were then incubated for 1 hr at 25°C with the following
primary antibodies: the rabbit polyclonal anti-Bek (1:50 in PBS; C-17;
Santa Cruz Biotechnology, sc-122) directed against the intracellular por-
tion of FGFR2 isoforms and mouse monoclonal anti-LAMP-2 (CD170b;
BD Biosciences, San Josè, CA, USA, 55803). The primary antibodies were
visualized using goat anti-rabbit IgG-Texas Red (1:200 in PBS; Jackson
ImmunoResearch Laboratories, West Grove, PA, USA, 111-075-144) and
goat antimouse IgG-Alexa Fluor 350 (1:20 in PBS; Life Technologies,
Carlsbad, CA, USA, A-11045) for 30 min. at 25°C. Nuclei were stained
with DAPI (1:1000 in PBS; Sigma-Aldrich, D9542). Coverslips were finally
mounted with Mowiol (Sigma-Aldrich, 81381) for observation.
Fluorescence signals were analysed by scanning cells in a series of
sequential sections with an ApoTome System (Zeiss, Oberkochen, Ger-
many, 000000-1189-776); image analysis was performed by the Axiovi-
sion software (Zeiss, 410130-9850-000), and 3D reconstruction of a
selection of three central optical sections is shown in each figure. Quan-
titative analysis of EGFP-LC3-positive dots per cell was performed ana-
lysing 100 cells for each sample in five different microscopy fields from
three different experiments. The EGFP-LC3-positive dots correspond to
the amount of the autophagosomes. In fact, the punctate staining of
EGFP-LC3 represents the autophagosome membrane-associated form of
LC3 (LC3-II), derived from the lipidation of the LC3 cytosolic form
(LC3-I). Quantitative analysis of the bead uptake was performed by
counting the number of internalized beads in 100 cells for each condi-
tion, randomly taken from 10 microscopic fields in three different exper-
iments. Quantitative analysis of the extent of colocalization of beads
with EGFP-LC3 and LAMP-2 was performed by the analysis of 100 cells
for each sample in five different fields randomly taken from three inde-
pendent experiments and using the KS300 3.0 Image Processing Sys-
tem (Zeiss, 000000-1020-771).
Results are expressed as mean values  S.E. P values were calcu-
lated using Student’s t-test, and significance level was defined as
P < 0.05.
Western blot analysis
Cells were lysed, and total protein was resolved by SDS-PAGE and trans-
ferred to reinforced nitrocellulose as previously described [10]. The mem-
branes were blocked with 5% non-fat dry milk (Bio-Rad Laboratories,
Hercules, CA, USA, 170-6404) in PBS/0.1% Tween-20 (Bio-Rad, 170-
6531) or with 3% BSA (Sigma-Aldrich, A7030) in PBS/0.1% Tween-20,
and incubated with anti-Bek polyclonal antibodies (C17; Santa Cruz
Biotechnology, sc-122), anti-LC3 polyclonal antibodies (MBL, Woburn,
MA, USA, PD014), anti-P-p44/42 MAPK (P-ERK1/2) polyclonal antibodies
(Thr202/Tyr204, Cell Signaling Technology, Beverly, MA, USA, 9101S),
anti-p-mTOR monoclonal antibody (Ser 2448, Cell Signaling, 5536), anti-
p-AKT polyclonal antibodies (Ser 473, Cell Signaling, 9271), anti-p-JNK
monoclonal antibody (G9, Cell Signaling, 9255S), anti-p-PKCd polyclonal
antibodies (Tyr-155; Santa Cruz Biotechnology, sc-23770-R), anti-p-PKCd
monoclonal antibody (Ser 645, Abcam, Cambridge, UK, ab108972), anti-
ULK1 polyclonal antibodies (H-240; Santa Cruz Biotechnology, sc-33182),
and anti-Rubicon monoclonal antibody (D9F7, Cell Signaling, 8465), fol-
lowed by enhanced chemiluminescence detection (ECL, Amersham,
Arlington Heights, IL, USA, 34080). The membranes were rehydrated by
washing in PBS/Tween-20, stripped with 100 mM mercaptoethanol and
2% SDS for 30 min. at 55°C and probed again with anti-mTOR mono-
clonal antibody (7C10, Cell Signaling, 2983), anti-AKT polyclonal antibod-
ies (H-136; Santa Cruz Biotechnology, sc-8312), anti-p44/42 MAPK
(ERK1/2) polyclonal antibodies (137F5, Cell Signaling, 4695S), anti-JNK
polyclonal antibodies (Cell Signaling, 9252S), anti-PKCd polyclonal anti-
bodies (C-20; Santa Cruz Biotechnology, sc-937), anti-b-actin monoclonal
antibody (Sigma-Aldrich, A5441) or anti-a-tubulin polyclonal antibodies
(Cell Signaling, 2148S) to estimate the protein equal loading. Densitomet-
ric analysis was performed with Quantity One program (Bio-Rad). Results
from three different experiments were normalized, expressed as fold
increase with respect to the control value and reported as mean values.
Transmission electron microscopy
HaCaT cells stimulated with FGF7 for 24 hrs and treated with red fluo-
rescent beads for the last 4 hrs as above were washed three times in
PBS and fixed with 2% glutaraldehyde (Electron Microscopy Science,
16300) in PBS for 2 hrs at 4°C. Samples were postfixed with 1%
osmium tetroxide in veronal acetate buffer (pH 7.4) for 1 hr at 25°C,
stained with uranyl acetate (5 mg/ml) for 1 hr at 25°C, dehydrated in
acetone and embedded in Epon 812 (EMbed 812, Electron Microscopy
Science). Ultrathin sections were examined unstained or poststained
with uranyl acetate and lead hydroxide, under a Morgagni 268D trans-
mission electron microscope (FEI, Hillsboro, OR, USA) equipped with a
MegaView II charge-coupled device camera (SIS, Soft Imaging System
GmbH, Munster, Germany) and analysed with AnalySIS software (SIS).
Results
FGFR2b-mediated phagocytosis and autophagy
are convergent pathways regulated by PLCc
signalling
We have recently demonstrated that FGFR2b expression and sig-
nalling trigger both autophagy [10] and phagocytosis [18, 20] in
human keratinocytes. To assess the existence of a possible interrela-
tionship between the two processes, when induced by FGF7 binding
to the receptor, and to ascertain whether they could involve converg-
ing autophagosomal and phagosomal compartments, we took advan-
tage of the use of an in vitro model of bead uptake widely used to
study the phagocytic ability of epidermal keratinocytes [24–26]. The
human keratinocyte HaCaT cell line [19] was transiently transfected
with the construct EGFP of the widely accepted marker for
autophagosomes LC3 [27, 28] (pEGFP-C2-LC3), serum-starved and
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stimulated with FGF7 for 24 hrs. For the last 4 hrs of the treatment,
cells were incubated also with inert latex red fluorescent beads
0.5 lm in diameter, whose size is comparable to that of melano-
somes [18, 20]. Concentrations of both FGF7 and beads, as well as
the times of treatments, were selected based on our published results
[18, 20, 29]. Cells were fixed and permeabilized, and nuclei were
stained with DAPI. Quantitative fluorescence analysis, performed as
reported in Materials and Methods, showed that while the serum
deprivation, which is a well-known autophagic stimulus, only
increased the number of the LC3-positive dots per cell, as expected
the treatment with FGF7 increased both the bead uptake [18, 20]
(Fig. 1A, left panels) and the amount of EGFP-LC3-positive dots per
cell [10] (Fig. 1A, left panels). In addition, only after FGF7 stimulation
the internalized beads partially colocalized with LC3 (18%) (Fig. 1A,
left panels). To confirm that the choice of 0.5-lm-diameter beads is
the most appropriate for our study, parallel experiments were per-
formed with larger beads (1 lm diameter). The results showed that,
even if both bead uptake and the number of LC3-positive dots per cell
were significantly increases by FGF7 stimulation, the amount of the
internalized beads was reduced, in particular following FGF7 treat-
ment (Fig. S1), when compared to that observed using 0.5-lm-sized
beads (see Fig. 1A, left panels). In addition, very poor colocalization
between the beads and the LC3-positive dots was observed (Fig. S1),
suggesting that the use of smaller size beads was the most suitable
condition to highlight the effect of FGF7 in inducing the convergence
between phagocytosis and autophagy.
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Fig. 2 Autophagy improves phagosome fusion with lysosomes in response to FGF7. HaCaT cells were transiently cotransfected with EGFP-LC3 and
with ULK1 siRNA, to inhibit autophagy, or with an unrelated siRNA as control, and then serum-starved and stimulated with FGF7 as above. Quantita-
tive immunofluorescence analysis performed with anti-LAMP-2 antibody shows that in unrelated siRNA-transfected samples, the low colocalization
between fluorescent beads and LAMP-2, which is detectable in cells grown in serum-added or in serum-deprived medium (left panels, arrows), is
significantly increased by FGF7 treatment (right panels, top, arrows); triple colocalization between LC3, beads and LAMP-2 is visible only in FGF7-
stimulated cells (right panels, top, arrows). All the FGF7-induced signal overlaps were strongly impaired by ULK1 silencing (right panels, bottom).
The quantitative analysis and Student’s t-test were performed as above: *P < 0.001 versus the corresponding FGF7-unstimulated cells; **P < 0.001
versus the corresponding control siRNA cells; NS versus the corresponding serum-cultured cells.
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Interestingly, in the experiments performed with 0.5-lm beads,
the not so tight colocalization and the presence of distal formation of
autophagosomes (LC3-positive dots which did not colocalize with
beads) strongly indicated that FGF7 induces LC3 association with
canonical newly formed autophagic vesicles and not directly with the
membrane of all the nascent phagosomes, as occurs during LAP. This
is consistent with the fact that inert beads are not able to activate LAP
[30]. To further confirm that LC3 was mainly associated with
autophagosomes and not with LAP-engaged phagosomes (LAPo-
somes), the stimulation with FGF7 was performed in cells in which
the canonical autophagy was inhibited through ULK1 protein deple-
tion by specific siRNA transfection. ULK1 is a component of the ULK
initiation complex required for canonical autophagy [31], but not for
LAP [32], and its depletion provides a useful tool for distinguishing
between the two processes [33]. On the other hand, to obtain specific
inhibition of LAP, we performed the depletion of Rubicon, which acti-
vates the UVRAG-containing class III PI(3)K complex exclusively
required for LAPosome formation [30] and represses the canonical
autophagy inhibiting the activity of Beclin 1–PI(3)K complex [34, 35].
The results showed that silencing of ULK1 did not affect bead uptake,
but significantly decreased the number of EGFP-LC3-positive dots per
cell, as well as the colocalization between these dots and the fluores-
cent beads (Fig. 1A, right panels). These results further suggested
that upon FGF7 stimulation, LC3 associates with nascent autophago-
somes but not with LAPosomes and that the colocalization between
LC3 and the fluorescent beads observed in untransfected cells or in
cells transfected with control siRNA possibly derives from the conflu-
ence between distinct phagosomes and autophagosomes. Consistent
with this possibility, Rubicon silencing resulted in an opposite effect,
enhancing the number of LC3-positive dots per cell and increasing,
although not significantly, their colocalization with fluorescent beads
(Fig. 1A, right panels). The efficient depletion of the ULK1 or Rubicon
proteins was verified in siRNA-transfected cells through Western blot
analysis (Fig. S2). To further confirm that the LC3-positive dots,
which colocalize with fluorescent beads, correspond to distinct
autophagosomal structures, electron microscopy studies were per-
formed in HaCaT cells stimulated with beads in the presence of FGF7
as above. Ultrastructural examination revealed the presence of single
(Fig. 1B i, ii and iii, asterisks) and clustered beads (Fig. 1B iv, aster-
isks) in either single-membrane (Fig. 1B ii, arrows) or more electron-
dense double-membrane (Fig. 1B ii, iii and iv, arrowheads) vacuoles
corresponding to phagosomes and autophagosomes, respectively.
Interestingly, the clustered beads collectively enclosed in a double-
membrane vacuole also appeared singly surrounded by a single
membrane (Fig. 1B iv, red arrows), suggesting that the autophago-
some could be generated and closed around phagosomes containing
the bead. Several clustered beads are also visible in vacuoles ultra-
structurally recognizable as lysosomes (data not shown), confirming
that the final fate for the engulfed beads is the degradative compart-
ment. These results clearly suggest that in response to FGF7, part of
the phagosomes containing the engulfed beads are isolated in new-
forming autophagosomes that possibly mediate their targeting to
lysosomes.
To verify whether FGF7-induced autophagy actually contributes to
increase the efficiency of phagosome fusion with lysosomes, triple-
immunofluorescence approaches were performed in HaCaT cells tran-
siently cotransfected with EGFP-LC3 and ULK1 siRNA, to inhibit the
autophagic process. Alternatively, cells were cotransfected with an
unrelated siRNA as control. Upon FGF7 stimulation performed as
above, cells were fixed and permeabilized and the immunostaining
with anti-LAMP-2 antibody was performed to visualize the lysosomal
compartment. Quantitative analysis showed that in cells transfected
with the unrelated siRNA, the low colocalization between fluorescent
beads and LAMP-2 visible in cells grown in serum-added (Fig. 2, left
panels, top, arrows) or in serum-deprived medium (Fig. 2, left panels,
bottom, arrows) was significantly increased by FGF7 stimulation
(Fig. 2, right panels, top, arrows), suggesting that the phagosomal
fusion with lysosomes was improved. In addition, the appearance of a
Fig. 3 The expression of the PLCc signalling mutant FGFR2b Y769F inhibits FGF7-induced autophagy. (A, B) HaCaT cells were transiently transfected
with the FGFR2b WT or with the Y769F FGFR2b mutant. The transfection with the kinase-negative Y656F/Y657F FGFR2b or with pCI-neo empty vec-
tor was performed as control. Upon transfection, cells were serum-starved and stimulated with FGF7 in the presence or absence of bafilomycin A1
for the last 3 hrs. (A) Western blot analysis shows that the increase in the levels of LC3-II upon FGF7 stimulation, visible in HaCaT pCI-neo and
even more in HaCaT FGFR2b WT cells, is further enhanced by bafilomycin A1; independent from the presence of this drug, FGFR2b Y769F cells
appear not responsive to FGF7. (B) FGFR2b Y769F expression, as well as FGFR2b kin expression, inhibits the increase in LC3-II levels induced by
FGF7 in FGFR2b WT cells. The equal loading was assessed using anti-ACTB antibody. For the densitometric analysis, the values from three indepen-
dent experiments were normalized, expressed as fold increase and reported in graph as mean values  S.D. Student’s t-test was performed, and
significance levels were defined as P < 0.05: (A) *P < 0.05 versus the corresponding FGF7-unstimulated cells, **P < 0.05 versus the correspond-
ing bafilomycin-untreated cells, NS versus the corresponding FGF7-unstimulated cells and versus the corresponding bafilomycin-untreated cells. (B)
*P < 0.05 versus the corresponding serum-cultured cells, **P < 0.05 versus the corresponding FGF7-unstimulated cells, NS versus the corre-
sponding FGF7-unstimulated cells. (C) HaCaT cells were transiently cotransfected with pEGFP-C2-LC3 construct and with the FGFR2b WT, with the
Y769F FGFR2b mutant, with the kinase-negative Y656F/Y657F FGFR2b or with pCI-neo empty vector and stimulated with FGF7 as above.
Immunofluorescence was performed with anti-FGFR2b polyclonal antibodies to visualize transfected FGFR2b WT or mutants. Upon FGF7 treatment,
the number of LC3-positive dots per cell is reduced in HaCaT EGFP-LC3/FGFR2b Y769F cells, as well as in HaCaT EGFP-LC3/FGFR2b kin cells,
compared to the surrounding cells not showing detectable receptor mutant overexpression (arrowheads), or to HaCaT EGFP-LC3/pCI-neo and HaCaT
EGFP-LC3/FGFR2b WT cells. Different from the kinase-negative dead mutant, both FGFR2b WT and FGFR2b Y769F signals appear internalized upon
FGF7 stimulation. The quantitative analysis and Student’s t-test were performed as above: *P < 0.05 versus HaCaT pCI-neo, **P < 0.001 versus
HaCaT FGFR2b WT cells. Bar: 10 lm.
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triple colocalization between LC3, beads and LAMP-2 only in
response to FGF7 (Fig. 2, right panels, top, arrows) clearly indicated
that this stimulation is able to drive phagosomes and autophago-
somes to converge and reach the degradative compartment. Interest-
ingly, the signal overlaps observed in FGF7-stimulated cells were
strongly impaired by ULK1 silencing (Fig. 2, right panels, bottom),
suggesting that the autophagic process is required for the improved
efficiency of the fusion between phagosomes and lysosomes induced
by FGF7.
Being PLCc activation/phosphorylation required for FGFR2b-
mediated phagocytosis [18], to investigate the role of this sig-
nalling in FGF7-induced autophagy we transiently transfected HaCaT
cells with a FGFR2b signalling mutant in which the tyrosine 769,
required for PLCc binding and activation [22, 36], has been substi-
tuted by phenylalanine (Y769F) [22]. The transfection with FGFR2b
wild-type (HaCaT FGFR2b WT) or with pCI-neo empty vector
(HaCaT pCI-neo) was used as control. After transfection, cells were
serum-starved and stimulated with FGF7 for 24 hrs and the amount
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of LC3-II was analysed by Western blot. To estimate whether PLCc
signalling shutdown could specifically impact on the autophago-
some assembly induced by FGF7, we compared cells in which the
autophagosome turnover was selectively blocked or not through
the treatment with bafilomycin A1, an inhibitor of the vacuolar-type
H+-ATPase (v-ATPase) able to block the fusion of autophagosomes
with lysosomes [23]. Different from other agents, including monen-
sin or chloroquine, bafilomycin A1 does not activate LC3 associa-
tion with single intracellular membranes, such as phagosomes, as
occurs during LAP [37]. The results showed that, as previously
demonstrated [10], the increase in LC3-II levels in response to
FGF7, evident in pCI-neo cells (Fig. 3A) and even more in FGFR2b
WT cells (Fig. 3A), was further increased by the presence of bafilo-
mycin A1 (Fig. 3A), confirming that FGF7 acts inducing autophago-
some formation. In contrast, independent from the treatment with
bafilomycin A1, FGFR2b Y769F-expressing cells did not display an
increase in LC3-II in response to FGF7 (Fig. 3A). Thus, PLCc sig-
nalling shutdown is sufficient to repress the autophagosome
assembly induced by FGF7. In agreement with this conclusion, the
effect observed in FGFR2b Y769F cells appeared comparable to that
detected in cells transfected with a Y656F/Y657F FGFR2b kinase
dead mutant (HaCaT FGFR2b kin) [21] (Fig. 3B). The impact of
PLCc signalling on FGF7-induced autophagy was also investigated
by fluorescence approaches. To this aim, HaCaT cells were alterna-
tively cotransfected with pEGFP-C2-LC3 construct and pCI-neo
empty vector, FGFR2b WT, FGFR2b kin or the FGFR2b Y769F.
Cells were then treated with FGF7 as above, fixed and permeabi-
lized, and nuclei were stained with DAPI. Quantitative immunofluo-
rescence analysis performed with anti-FGFR2b polyclonal
antibodies, to visualize transfected FGFR2b WT or mutants, showed
that similar to FGFR2b kin, FGFR2b Y769F overexpression induced
a drastic reduction of the number of LC3-positive dots compared
to that observed in HaCaT EGFP-LC3/pCI-neo and in HaCaT EGFP-
LC3/FGFR2b WT cells (Fig. 3C) or in HaCaT EGFP-LC3/FGFR2b
Y769F and in EGFP-LC3/FGFR2b kin surrounding cells not show-
ing detectable receptor mutant overexpression (Fig. 3C, arrow-
heads). These results indicate that similar to that previously
demonstrated for FGF7-induced phagocytosis [18], the overexpres-
sion of FGFR2b Y769F or FGFR2b kin exerts an inhibitory effect
also on FGF7-induced autophagy. On the other hand, different from
what was observed for the receptor kinase dead mutant (Fig. 3C),
upon FGF7 stimulation both FGFR2b WT and FGFR2b Y769F signals
appeared concentrated in intracellular dots (Fig. 3C), confirming
that PLCc signalling is not required for receptor internalization
[22]. Overall, our lines of evidence strongly suggest that the speci-
fic signalling downstream PLCc is required for FGF7-induced
autophagosome formation and that its shutdown results in a signif-
icant inhibition of the process.
FGFR2b-induced autophagy requires PLCc-
mediated phosphorylation/activation of JNK
Autophagy can be controlled by several MTOR-dependent or MTOR-
independent signalling pathways [38, 39]. While it has been demon-
strated that FGF2 negatively impacts on autophagy through the acti-
vation of AKT/MTOR signalling [40, 41], we have recently
demonstrated that FGF7 increases autophagy through a not yet identi-
fied PI3K/AKT/MTOR-independent pathway [10]. Therefore, we
focused our attention on the JNK1-mediated signalling pathway,
which is MTOR-independent [39], and it has been recently identified
as mainly involved in FGFR4-mediated autophagy in chondrocytes
[42]. To assess the possible impact of the JNK1 pathway in FGF7-
mediated autophagy, and to establish whether and how PLCc is
involved in the activation of the JNK1 pathway, we compared the
levels of phosphorylation/activation of this kinase and of other impor-
tant FGFR2b signalling substrates involved in the control of autop-
hagy, such as ERK1/2, in HaCaT pCI-neo, HaCaT FGFR2b WT cells
and HaCaT FGFR2b Y769F cells. Both AKT and MTOR phosphoryla-
tion was checked to further confirm the independence of FGF7-
mediated autophagy from the canonical PI3K/AKT/MTOR regulating
pathway. Western blot analysis showed that upon FGF7 stimulation,
all the checked substrates appeared phosphorylated in HaCaT pCI-
neo and HaCaT FGFR2b WT cultures, indicating that in these cells all
the signalling pathways downstream FGFR2b are activated (Fig. 4A).
In particular, the phosphorylation/activation of MTOR at serine 2448
(Ser2448) site (Fig. 4A) further confirmed the independence of FGF7-
induced autophagy by this signalling pathway. More interestingly, in
HaCaT FGFR2b Y769F cells AKT, MTOR and ERK1/2 appeared nor-
mally phosphorylated, while JNK1 phosphorylation at threonine 183
and tyrosine 185 sites (Thr183/Tyr185) was significantly reduced
(Fig. 4A). These lines of evidence indicated that PLCc recruitment to
FGFR2b and its consequent phosphorylation are required for an effi-
cient activation of the JNK1-mediated signalling pathway. JNK1 path-
way is canonically activated by several MAP3 kinases, which in turn
activate MKK4 and MKK7 that induce JNK phosphorylation [5]. How-
ever, it has been recently demonstrated that PKCd is the upstream
substrate mainly responsible for the activation of the JNK1 pathway,
Fig. 4 The inhibition of PLCc signalling is accompanied by JNK pathway shutdown and PKCd inactivation. (A, B) HaCaT pCI-neo, HaCaT FGFR2b WT
and HaCaT FGFR2b Y769F cells were serum-starved and stimulated with FGF7 as above. Western blot analysis shows that in response to FGF7 stim-
ulation, the phosphorylation of both JNK1 (A) and PKCd, at the tyrosine 155 site (B), appears attenuated only in HaCaT FGFR2b Y769F cells, while
MTOR (Ser 2448), AKT and ERK1/2 substrates (A) are highly phosphorylated in all cells. The equal loading was assessed using anti-MTOR, anti-
AKT, anti-ERK1/2, anti-JNK1/2 and anti-PKCd antibodies. Housekeeping gene bands (ACTB, tubulin or GAPDH) are also shown. The densitometric
analysis and Student’s t-test were performed as reported above: (A) *P < 0.05 versus the corresponding FGF7-unstimulated cells; **P < 0.01 ver-
sus the corresponding FGF7-unstimulated cells. (B) *P < 0.05 versus the corresponding FGF7-unstimulated cells; NS versus the corresponding
FGF7-unstimulated cells.
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during hypoxia-mediated autophagy [7, 43]. PKCd is a substrate
which is activated via PLCc [44] also upon the activation of FGFRs,
including FGFR2 [45]. To establish the relevance of PKCd activation in
the triggering of FGF7-mediated autophagy, we compared its phos-
phorylation levels at the tyrosine 155 site in cells alternatively overex-
pressing FGFR2b or FGFR2b Y769F or pCI-neo as control. In fact, Tyr
155 is one of the crucial residues whose phosphorylation is required
for PKCd upon different stimuli. Western blot analysis clearly
demonstrated that in agreement with the observed attenuation of
JNK1 phosphorylation, a corresponding reduction of PKCd phospho-
rylation at the tyrosine 155 site was detectable in cells overexpressing
FGFR2b Y769F (Fig. 4B). These findings suggest that in FGFR2b
Y769F cells, the observed impairment of FGF7-induced autophagy is
due to the inhibition of PLCc-mediated signalling, which could involve
the block of PKCd activation and consequent JNK1 pathway shut-
down.
To ascertain the relevance of JNK1 repression for the block of
FGF7-induced autophagy observed in cells expressing FGFR2b PLCc
signalling mutant, we estimated the impact of specific kinase inhibi-
tors on LC3-II levels in either HaCaT pCI-neo or HaCaT FGFR2b WT.
For JNK1, we took advantage of the JNK inhibitor (SP600125) also
used to interfere with FGF18/FGFR4-triggered JNK-mediated autop-
hagy [42], while the impairment of ERK1/2 signalling was obtained
using the inhibitor of the upstream substrates MEK1/2, which effi-
ciently block this pathway during ligand-mediated activation of FGFRs
[46]. The effect of the AKT inhibitor previously described by us
[10, 47] was checked again to further confirm that FGF7-mediated
autophagy is independent from the canonical PI3K/AKT/MTOR path-
way. Western blot analysis performed with antibodies directed against
the phosphorylated forms of each substrate confirmed that all the
inhibitors were highly specific. In fact, AKT inhibitor selectively
reduced AKT phosphorylation (Fig. S3A), while MEK1/2 inhibitor
blocked the phosphorylation of the MEK substrates ERK1/2
(Fig. S3B). In addition, JNK inhibitor strongly impaired the Thr183/
Tyr185 phosphorylation/activation in both JNK1 and JNK2 (Fig. S3C),
and this effect, already previously documented, has been explained
by the inhibition of the JNK autophosphorylating activity [48, 49]. In
the second step, we analysed the effects of the different substrate
inhibitors on the LC3-II modulation induced by FGF7 in either HaCaT
pCI-neo or HaCaT FGFR2b WT cells. Results showed that while both
AKT and MEK1/2 inhibitors were ineffective (Fig. 5A and B), the JNK
inhibitor clearly interfered with the increase in LC3-II induced by FGF7
(Fig. 5C). As we have postulated that PKCd could be a possible down-
stream PLCc substrate acting upstream JNK1, we also analysed the
effect of the direct inhibition of PKCd on FGF7-mediated autophagy.
For this aim, we took advantage from rottlerin inhibitor, previously
used to demonstrate the involvement of PKCd in FGF/FGFR signalling
pathways [45]. Western blot analysis clearly showed that rottlerin
exerted a repressive effect on FGF7-induced LC3-II increase (Fig. 5D)
which was comparable to that induced by JNK inhibitor (Fig. 5C) or
by PLCc signalling shutdown in FGFR2b Y769F-expressing cells
(Fig. 3A). The efficiency of rottlerin was confirmed by its ability to
induce a strong decrease in phosphorylation of the autophosphoryla-
tion site tyrosine 645 (tyrosine 643 in rat) [50] in PKCd (Fig. S4); in
addition, the evident repression of JNK1 phosphorylation (Fig. S4)
confirmed the hypothesis that JNK1 is a downstream PKCd substrate.
Overall, our results suggest that the PLCc signalling pathway is the
main pathway responsible for the triggering of FGFR2b-induced
autophagy. The use of specific inhibitors confirmed that the autopha-
gic process controlled by FGFR2b is PI3K/AKT/MTOR-independent
and requires JNK1 phosphorylation/activation, which possibly occurs
via PKCd activation.
FGFR2b enhances FGF7-mediated autophagy,
phagocytosis and their convergence in light skin
primary HKs
We have previously demonstrated that FGFR2b-induced PLCc sig-
nalling is required for FGF7-stimulated phagocytosis and consequent
melanosome uptake in keratinocytes [18]; here, we demonstrated that
the same signalling pathway is involved in FGFR2b-mediated autop-
hagy in these cells and that FGF7-mediated phagocytosis and autop-
hagy are converging pathways to possibly ensure melanosome
degradation. In agreement with this possibility, in HKs from light skin,
where FGFR2b-mediated uptake of the melanosomes is higher than in
HKs from dark skin as a consequence of an higher expression of
FGFR2b [29], the reduced number of intracellular melanosomes was
the consequence of an accelerated ability to degrade them by autop-
hagy [51]. In a recent work, we also speculated that in light skin HKs,
FGFR2b, in virtue of its ability to accelerate the autophagosome turn-
over, could be responsible for melanosome removal via autophagy
Fig. 5 The inhibition of either JNK1 or PKCd substrate blocks FGFR2b-induced autophagy. (A, B, C, D) HaCaT pCI-neo and HaCaT FGFR2b WT were
serum-starved and stimulated with FGF7 in the presence or absence of the indicated substrate inhibitors as reported in Materials and Methods. Wes-
tern blot analysis shows that either AKT inhibitor (A) or MEK1/2 inhibitor (B) does not affect the increase in LC3-II levels induced by FGF7, while
JNK inhibitor (C) and PKCd inhibitor (D) attenuate it. The equal loading was assessed with anti-ACTB antibody. The densitometric analysis and Stu-
dent’s t-test were performed as reported above: (A) *P < 0.05 versus the corresponding FGF7-unstimulated cells; **P < 0.05 versus the corre-
sponding FGF7-stimulated cells; ***P < 0.01 versus the corresponding FGF7-unstimulated cells; NS versus HaCaT pCI-neo cells. (B) *P < 0.05
versus the corresponding FGF7-unstimulated cells; **P < 0.01 versus HaCaT pCI-neo cells; ***P < 0.01 versus the corresponding FGF7-unstimu-
lated cells; NS versus the corresponding MEK1/2 inhibitor-untreated cells. (C) *P < 0.05 versus the corresponding FGF7-unstimulated cells;
**P < 0.01 versus the corresponding FGF7-stimulated cells; ***P < 0.01 versus HaCaT pCI-neo cells; ****P < 0.01 versus the corresponding
FGF7-unstimulated cells; NS versus the corresponding JNK inhibitor-untreated cells. (D) *P < 0.05 versus the corresponding FGF7-unstimulated
cells; **P < 0.05 versus the corresponding FGF7-stimulated cells; ***P < 0.01 versus HaCaT pCI-neo cells; NS versus the corresponding PKCd
inhibitor-untreated cells.
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[10]. On the basis of this hypothesis, we wondered whether FGFR2b
could be involved not only in the regulation of both phagocytosis and
autophagy, but also in the fine control of their balance. To ascertain
it, we used again the in vitro model of bead uptake and we compared
the ability of HKs from light and dark skin to either engulf or sort the
engulfed beads to the degradation via autophagy in response to FGF7.
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To this aim, light and dark keratinocytes were transiently trans-
fected with pEGFP-C2-LC3 construct, serum-starved and treated
with FGF7 and with inert latex red fluorescent beads as above.
Quantitative fluorescence analysis performed as reported in Materi-
als and Methods confirmed that as expected [29] and consistent
with the increased expression of FGFR2b (Fig. S5), the treatment
with FGF7 increased the bead uptake more in light skin ker-
atinocytes than in the dark ones (Fig. 6A). In addition, in light skin
HKs, FGF7 stimulation significantly increased the amount of EGFP-
LC3-positive dots per cell more than in the dark ones and a part of
beads (26%) colocalized with them (Fig. 6A). These results indicate
that in light skin HKs, but not in the dark ones, the uptake of beads
and their confluence in nascent autophagosomes for sorting to
degradation are both enhanced by FGF7 stimulation. Interestingly,
the transient transfection of dark skin HKs with FGFR2b (dark skin
HKs FGFR2b) restored conditions comparable to those observed in
light skin HKs in terms of bead internalization, autophagosome for-
mation and bead/LC3 colocalization (Fig. 6A), confirming that the
promotion of these events in response to FGF7 directly depends on
FGFR2b expression. In addition, the effects observed in light skin
keratinocytes in response to FGF7 appeared strongly dampened by
the addition of the specific FGFR2 tyrosine kinase inhibitor SU5402
(Fig. 6B), indicating that FGFR2b activation and signalling are
required.
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responding FGF7-unstimulated cells; **P < 0.05 versus the corresponding FGF7-unstimulated cells; ***P < 0.001 versus the corresponding
untransfected dark skin HKs; NS versus the corresponding serum-cultured cells; •P < 0.01 versus the corresponding serum-cultured cells;
••P < 0.01 versus the corresponding FGF7-unstimulated cells; •••P < 0.05 versus the corresponding FGF7-unstimulated cells; ••••P < 0.01 versus
the corresponding untransfected dark skin HKs; ^P < 0.05 versus the corresponding FGF7-unstimulated cells; ^^P < 0.001 versus the correspond-
ing untransfected dark skin HKs; NS versus the corresponding FGF7-unstimulated cells. Bar: 10 lm. (B) HKs from light skin were treated with FGF7
and fluorescent beads as above in the presence of the FGFR2 inhibitor SU5402 as reported in Material and Methods. The bead uptake, the number
of LC3-positive dots per cell and the bead/LC3 colocalization are significantly reduced by SU5402. The quantitative analysis and Student’s t-test were
performed as above: *P < 0.05 versus the corresponding FGF7-stimulated cells; **P < 0.01 versus the corresponding FGF7-stimulated cells. Bar:
10 lm
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Discussion
The interplay between autophagy and phagocytosis is known to occur
in the context of macrophages [12–16]; however, a similar crosstalk
has not been already described in other cell types. In this study, not
only we confirmed our previous results showing that in human ker-
atinocytes, FGF7 stimulation of its receptor FGFR2b is able to trigger
both phagocytosis [18] and autophagy [10], but interestingly we
found that the receptor activation is able to drive phagosomes and
autophagosomes to converge and to reach the lysosomal compart-
ment. This phenomenon might be explained as an additional strategy
of this type of cells to more efficiently redirect the engulfed material
towards a degradative fate.
It has been reported that in addition to the conventional autop-
hagy, several non-canonical autophagic mechanisms can be activated
and, in particular, a direct recruitment of BECN1 and LC3 to the
phagosomal membranes has been described in murine macrophages
during phagocytosis and called LAP [16]. However, our findings
strongly indicate that in our cell model, the autophagic process
mainly involves a canonical pathway to isolate the newly formed
phagosomes. In fact, our fluorescence results, showing a not
complete colocalization between the internalized beads and the LC3-
positive dots upon FGF7 stimulation, appear to exclude the involve-
ment of a non-canonical autophagy, such as LAP. This conclusion is
further sustained by the results obtained through alternative depletion
of components selectively required for autophagy or LAP pathways,
such as ULK1 and Rubicon, respectively, and by the choice to use for
our experiments inert latex beads, which do not per se induce LAP
[30]. In addition, our ultrastructural analysis strongly indicates that
autophagosomal structures might close around phagosomes contain-
ing the beads and that this canonical intracellular membrane pathway
may represent the main mechanism involved in such convergence of
the two processes. However, several single-membrane organelles
containing beads were also visible; therefore, we may speculate that
as previously described in macrophages during bacterial clearance
[52], also in keratinocytes other mechanisms, including the fusion
between the phagosomal membrane and the outer membrane of
autophagosomes, cannot be excluded. Further work could be
addressed to investigate whether FGF7 can interfere with LAP acti-
vated by specific stimuli, such as the treatment with zymosan or IgG
beads [17, 30].
The ability of FGFR2b to regulate the phagocytic process
appears to be functionally linked to the control of the melanosome
uptake by recipient keratinocytes for skin pigmentation [18, 20]. In
fact, this ability in response to FGF7 is more efficient in HKs from
light skin, which are known to express more FGFR2b compared to
those from dark skin [29]. In the other hands, a recent study high-
lighted the crucial role of the autophagic process in melanosome
degradation in the context of human keratinocytes [51]. Our pre-
sent results, indicating a key role of FGFR2b not only in the induc-
tion of both autophagy and phagocytosis, but also in the regulation
of their convergence, encouraged us to envisage a new scenario in
which FGFR2b would differently control autophagy, and possibly
melanosome turnover, in light and dark skin. This hypothesis
appears to be strongly confirmed by our results obtained increas-
ing the levels of FGFR2b expression in dark skin HKs through
transfection: in fact, the forced expression of the receptor is not
only able to enhance the bead uptake and the number of
autophagosomes, but also promotes the autophagosomal/phago-
somal convergence. This last evidence appears to unequivocally
indicate that the divergent behaviour of HKs from differently pig-
mented skin in terms of melanosome uptake and clearance would
be mainly ascribed to differences in FGFR2b expression. Taken
together, our results suggest that through a fine modulation of the
interplay between phagocytosis and autophagy, FGFR2b activation
and signalling are crucial in determining melanosome intracellular
amount and consequently skin pigmentation. Our speculations are
consistent with those of Li and coworkers [53], which suggested
that the UVB-induced persistence of melanosomes, especially in
HKs from light skin, can be due to the inhibition of autophagy con-
sequent to UVB-mediated internalization and degradation of
FGFR2b [21, 54]. These authors also proposed that the modulation
of FGF7-induced autophagy might be a useful strategy for treating
skin pigmentation disorders [53].
While in our previous work [18] we have demonstrated that in
human keratinocytes, the FGFR2b-induced phagocytosis occurs via
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Fig. 7 Schematic drawing of the proposed role of FGFR2b and its PLCc
signalling in the regulation of interplay between autophagy and phago-
cytosis. FGF7-mediated FGFR2b activation induces phosphorylation of
the Y769 residue, which is required for activation and recruitment of
PLCc to the receptor. PLCc signalling in turn induces both phagocytosis
through diacylglycerol (DAG) formation and autophagy through JNK1
activation via PKCd. The two membrane pathways partially converge
towards lysosomal degradation.
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PLCc signalling, suggesting that diacylglycerol formation and conse-
quent cortical actin reorganization could be required, the molecular
pathways responsible for FGF7-induced autophagy have not been
clarified in our more recent studies [10, 11]. It is well known that
the autophagic process can be regulated by either MTOR-depen-
dent or MTOR-independent molecular mechanisms [38, 39], and
we have previously demonstrated that FGF7-mediated autophagy is
a PI3K/AKT/MTOR-independent process [10]. In this study, we fur-
ther progress on the identification of the molecular mechanisms
underlying FGF7-mediated autophagy, identifying PLCc as a crucial
player acting downstream FGFR2b. Using biochemical and
immunofluorescence approaches, we assessed the key role of the
tyrosine 769 residue in FGFR2b, responsible for the activation/re-
cruitment of PLCc, not only in the receptor-mediated phagocytosis
as previously shown [18], but also in the induction of autophagy. In
fact, the point mutation of this receptor site, which generates the
PLCc signalling dead mutant FGFR2b Y769F, resulted in the impair-
ment of the autophagosome formation following FGF7 stimulation.
Thus, PLCc signalling appears to be the main pathway involved in
the regulation of both FGFR2b-mediated phagocytosis and autop-
hagy (Fig. 7).
Then, to identify the molecular machinery acting downstream
PLCc, we focused our attention on JNK1, a RTK substrate able to acti-
vate an MTOR-independent autophagic pathway [39] and recently
identified as the main player involved in FGFR4-mediated autophagy
[42]. We found that upon FGF7 stimulation, the phosphorylation/acti-
vation of JNK1 is strongly attenuated in cells overexpressing the
FGFR2b Y769F mutant. Moreover, only the inhibition of JNK1, but not
that of other FGFR2b substrates, such as MEK1/2 or AKT, was able to
affect FGF7-mediated autophagy. These findings demonstrated that
consistent with what has been reported for FGFR4 in chondrocytes
[42], FGFR2b-mediated autophagy in keratinocytes is induced via the
activation of JNK1 signalling. Taking advantage of the use of a speci-
fic inhibitor, we finally identified PKCd as the molecular player down-
stream PLCc [44] directly involved in JNK1 activation and
consequently in FGF7-induced autophagy. These results are consis-
tent with previous findings indicating PKCd as crucial activator of
JNK1 pathway during autophagy induced by hypoxia [7, 43].
Overall, our data strongly suggest that PLCc is the FGFR2b sub-
strate, which acts as an upstream regulator of both phagocytosis and
autophagy in HKs. While the PLCc-mediated formation of diacylglyc-
erol and consequent cortical actin reorganization might be responsi-
ble for the triggering of phagocytosis, PKCd/JNK1 signalling would be
the main downstream PLCc pathway required for the induction of
FGF7-mediated autophagy (Fig. 7).
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